Concepedia

Publication | Open Access

L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab

15

Citations

46

References

2023

Year

References

YearCitations

Page 1